ASH 2016: Cutaneous T-Cell Lymphoma Treatment News

: 0 Comments

On location at the 2016 American Society of Hematology (ASH) meeting, Dr. Steven Horwitz of Memorial Sloan Kettering Cancer Center explores new and emerging treatments for cutaneous T-cell lymphoma, including the results of the ALCANZA Trial. Dr. Horwitz provides an overview of the disease and shares advice for discussing a new treatment approach with your physician.

Sponsored by Seattle Genetics.

Sign in or Register to view comments.